Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Cutaneous T-cell lymphoma stage II
ADR ID BADD_A09756
ADR Hierarchy
01      Blood and lymphatic system disorders
01.11      Lymphomas non-Hodgkin's T-cell
01.11.03      Mycoses fungoides
01.11.03.006      Cutaneous T-cell lymphoma stage II
23      Skin and subcutaneous tissue disorders
23.07      Skin and subcutaneous tissue disorders NEC
23.07.04      Skin and subcutaneous conditions NEC
23.07.04.033      Cutaneous T-cell lymphoma stage II
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.17      Lymphomas non-Hodgkin's T-cell
16.17.03      Mycoses fungoides
16.17.03.006      Cutaneous T-cell lymphoma stage II
Description Not Available
MedDRA Code 10011681
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cerebriform T lymphoma (Lukes-Collins Classification) stage II | Cutaneous T-cell lymphoma stage II | Mycosis fungoides (Working Formulation) stage II | Mycosis fungoides stage II | Mycosis fungoides/Sezary syndrome stage II | Sezary syndrome stage II | Sezary's disease stage II | Sezary's syndrome stage II | Small cell cerebriform (Mycosis fungoides sezary syndrome) (Kiel Classification) stage II
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01083Hydrochlorothiazide0.000015%
The 1th Page    1    Total 1 Pages